Foresight is an independent infrastructure and private equity investment manager operating across multiple asset classes and regions. The firm manages about £700m through its private equity team across a portfolio of more than 100 companies.
Portfolio
5
companies
AUM
£6800M
under management
WorkBuzz
WorkBuzz provides a platform that connects businesses with staff to gather real-time feedback.
Titania
Titania provides automated cybersecurity assessment software for network devices.
Fourth Wall Creative
Fourth Wall Creative provides automated merchandising and fulfilment solutions for the football industry.
Spektrix
Spektrix builds cloud software for arts ticketing, marketing and fundraising.
Fertility Focus
Fertility Focus manufactures fertility monitoring products for women experiencing difficulties conceiving.
Rob Jones
Investment Manager
Rob is a director at Foresight Group, where he serves as an investment manager. He also holds investor director roles across several companies, including Roxy Leisure and Steamforged Games.
LinkedIn
Matthew Evans-Young
Investment Manager
Matthew brings investment and financial leadership experience, having previously served as CFO at Atom Learning and Investment Director at Foresight Group. He is now a founding partner at Hypha Private Equity.
LinkedIn
David Miles
Investment Manager
David serves as a director at Foresight Group, alongside holding non-executive director roles across several companies.
LinkedIn
Stephan Gueorguiev
Investment Director
Stephan brings investment experience from Foresight, alongside non-executive director roles across several companies.
LinkedInThe funding round was backed by Mercia and Foresight through the Midlands Engine Investment Fund alongside private investors.
"The world of work is changing, with many people working remotely and using video calls or emails to communicate. WorkBuzz helps companies to navigate these challenges and build great cultures. Our vision is to improve the working lives of 1 million people, and this investment round will help us to make it happen sooner."
Foresight backed the Worcestershire cybersecurity software provider with growth capital to scale operations.
"Titania’s mission is to increase our customers’ network resilience and security compliance, and Foresight’s backing and investment will accelerate our ambitious plans to automatically detect and remediate mis-configurations and vulnerabilities at scale and reduce customers’ attacks while evidencing compliance. Delivering this at scale is especially important in a world in which organisations need to move from occasional auditing through to continuous monitoring of network security. Foresight will support us in achieving our goals, enabling our customers and partners to use Titania as a cornerstone solution in the global Vulnerability Managed Detection and Response technology stack and market."
The Merseyside company raised £5m in growth capital led by Foresight Group to expand into new markets and develop software.
"Fourth Wall Creative has grown rapidly in recent years due to its exceptional reputation in the football sector. Throughout the process we have been impressed by the team’s ambition and commitment to innovation and quality of service. We are very excited to partner with Anton and the team to support the Company in continuing on its impressive growth trajectory."
Foresight has taken a minority equity position in the business through its venture capital trusts.
"The goal of Spektrix is to empower arts and entertainment organisations with the tools they need to excel in the evolving arts economy. This injection of growth capital gives us additional resources to expand strategically, increase the pace of innovation, and fully realise our ambitions for the sector on both sides of the Atlantic."
Foresight Group led the £1.3m investment to fund sales, marketing, and clinical trials.
"We have been impressed by the rapid progress FFL has made since launch of the second-generation OvuSense product with strong sales traction in the US and UK. FFL is a well-run business that has developed an innovative, clinically supported and IP rich product in OvuSense. We are looking forward to working alongside Rob Milnes and the wider management team on the next stage of the Company’s growth."